Elisabeth Dianne Riviello, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sepsis | 6 | 2021 | 2587 | 1.030 |
Why?
|
Rwanda | 8 | 2021 | 665 | 0.960 |
Why?
|
Critical Care | 11 | 2023 | 2697 | 0.950 |
Why?
|
Hospital Mortality | 8 | 2021 | 5291 | 0.780 |
Why?
|
Health Resources | 6 | 2019 | 935 | 0.770 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2020 | 410 | 0.690 |
Why?
|
Health Care Rationing | 2 | 2022 | 437 | 0.650 |
Why?
|
Oximetry | 3 | 2024 | 460 | 0.620 |
Why?
|
Oxygen | 6 | 2024 | 4227 | 0.620 |
Why?
|
Standard of Care | 1 | 2022 | 550 | 0.600 |
Why?
|
Hyperoxia | 1 | 2019 | 258 | 0.570 |
Why?
|
Intensive Care Units | 9 | 2021 | 3744 | 0.540 |
Why?
|
Drug Resistance, Microbial | 1 | 2019 | 857 | 0.530 |
Why?
|
Developing Countries | 8 | 2022 | 2887 | 0.500 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 589 | 0.480 |
Why?
|
Respiration, Artificial | 6 | 2023 | 2625 | 0.470 |
Why?
|
Positive-Pressure Respiration | 2 | 2023 | 639 | 0.450 |
Why?
|
Residence Characteristics | 1 | 2022 | 2092 | 0.390 |
Why?
|
Bacterial Infections | 1 | 2019 | 1406 | 0.370 |
Why?
|
Cross Infection | 1 | 2019 | 1438 | 0.350 |
Why?
|
Life | 1 | 2008 | 13 | 0.320 |
Why?
|
Blood Transfusion | 1 | 2015 | 1299 | 0.310 |
Why?
|
Mining | 1 | 2007 | 93 | 0.280 |
Why?
|
Capacity Building | 2 | 2020 | 258 | 0.280 |
Why?
|
Kidney Tubules | 1 | 2009 | 449 | 0.280 |
Why?
|
Immunologic Factors | 1 | 2015 | 1589 | 0.260 |
Why?
|
Attitude to Death | 1 | 2008 | 400 | 0.250 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2016 | 1461 | 0.240 |
Why?
|
Health Priorities | 2 | 2022 | 374 | 0.230 |
Why?
|
Gadolinium | 1 | 2009 | 960 | 0.220 |
Why?
|
Kenya | 3 | 2023 | 758 | 0.220 |
Why?
|
Biomedical Research | 4 | 2019 | 3429 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.220 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2490 | 0.200 |
Why?
|
Critical Illness | 4 | 2019 | 2722 | 0.190 |
Why?
|
Decision Making | 1 | 2015 | 3929 | 0.190 |
Why?
|
Occupational Health | 1 | 2007 | 806 | 0.190 |
Why?
|
Respiratory Insufficiency | 2 | 2020 | 1230 | 0.190 |
Why?
|
Berlin | 2 | 2017 | 23 | 0.180 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7439 | 0.180 |
Why?
|
Lung | 4 | 2021 | 9994 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7872 | 0.170 |
Why?
|
Ventilators, Mechanical | 1 | 2022 | 288 | 0.170 |
Why?
|
Acute Kidney Injury | 2 | 2009 | 1926 | 0.170 |
Why?
|
Delirium | 2 | 2021 | 1667 | 0.160 |
Why?
|
Registries | 1 | 2015 | 8223 | 0.160 |
Why?
|
Family Conflict | 1 | 2019 | 95 | 0.160 |
Why?
|
Humans | 41 | 2024 | 761326 | 0.160 |
Why?
|
Models, Biological | 1 | 2015 | 9468 | 0.160 |
Why?
|
Blood Gas Analysis | 1 | 2019 | 379 | 0.150 |
Why?
|
Enterobacteriaceae | 1 | 2019 | 174 | 0.150 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 221 | 0.150 |
Why?
|
Gram-Negative Bacteria | 1 | 2019 | 272 | 0.150 |
Why?
|
Hospitals, University | 1 | 2019 | 564 | 0.150 |
Why?
|
Hospitals | 2 | 2021 | 3878 | 0.140 |
Why?
|
Vasoconstrictor Agents | 1 | 2021 | 654 | 0.140 |
Why?
|
beta-Lactamases | 1 | 2019 | 307 | 0.140 |
Why?
|
Fluid Therapy | 1 | 2021 | 581 | 0.140 |
Why?
|
Sputum | 1 | 2019 | 506 | 0.140 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 495 | 0.140 |
Why?
|
Vulnerable Populations | 1 | 2022 | 702 | 0.130 |
Why?
|
Tuberculosis, Miliary | 1 | 2016 | 13 | 0.130 |
Why?
|
Meningitis, Cryptococcal | 1 | 2016 | 67 | 0.130 |
Why?
|
Contrast Media | 1 | 2009 | 5310 | 0.130 |
Why?
|
Physician-Patient Relations | 1 | 2008 | 3249 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2009 | 2241 | 0.120 |
Why?
|
Adult | 13 | 2023 | 221122 | 0.120 |
Why?
|
Shock, Septic | 1 | 2021 | 768 | 0.120 |
Why?
|
Education, Medical | 2 | 2020 | 1725 | 0.120 |
Why?
|
Hospitals, Public | 1 | 2016 | 202 | 0.120 |
Why?
|
Career Choice | 1 | 2020 | 756 | 0.110 |
Why?
|
Quality Improvement | 2 | 2019 | 3800 | 0.110 |
Why?
|
Middle Aged | 11 | 2022 | 220774 | 0.110 |
Why?
|
Male | 14 | 2023 | 360621 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3572 | 0.110 |
Why?
|
Information Dissemination | 1 | 2021 | 1127 | 0.110 |
Why?
|
Female | 14 | 2023 | 392485 | 0.100 |
Why?
|
Botswana | 2 | 2023 | 1048 | 0.100 |
Why?
|
Mortality | 2 | 2021 | 2898 | 0.100 |
Why?
|
Hospitalization | 2 | 2022 | 10715 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1760 | 0.090 |
Why?
|
Demography | 1 | 2016 | 1648 | 0.090 |
Why?
|
Quality of Health Care | 3 | 2018 | 4330 | 0.090 |
Why?
|
Disabled Persons | 1 | 2021 | 1225 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20092 | 0.090 |
Why?
|
Income | 2 | 2022 | 1876 | 0.090 |
Why?
|
Probability | 1 | 2016 | 2478 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7999 | 0.090 |
Why?
|
Zambia | 2 | 2021 | 262 | 0.090 |
Why?
|
Ultrasonography | 3 | 2021 | 5970 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1212 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1419 | 0.080 |
Why?
|
Angola | 1 | 2008 | 19 | 0.080 |
Why?
|
Boston | 1 | 2022 | 9333 | 0.080 |
Why?
|
Malaria | 1 | 2018 | 1227 | 0.080 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7389 | 0.080 |
Why?
|
Biomedical Technology | 1 | 2011 | 210 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2022 | 80575 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1780 | 0.080 |
Why?
|
Internship and Residency | 1 | 2008 | 5877 | 0.080 |
Why?
|
Prospective Studies | 4 | 2024 | 54405 | 0.070 |
Why?
|
Length of Stay | 1 | 2021 | 6422 | 0.070 |
Why?
|
Poverty | 2 | 2016 | 2697 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3687 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15835 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3597 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3357 | 0.070 |
Why?
|
Renal Replacement Therapy | 1 | 2008 | 282 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4591 | 0.060 |
Why?
|
Pandemics | 2 | 2022 | 8635 | 0.060 |
Why?
|
Health Personnel | 1 | 2019 | 3335 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6815 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 6966 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2021 | 64645 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9605 | 0.060 |
Why?
|
Incidence | 2 | 2016 | 21336 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2019 | 5334 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3243 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 5492 | 0.050 |
Why?
|
Forecasting | 1 | 2011 | 2928 | 0.050 |
Why?
|
CD4 Lymphocyte Count | 1 | 2007 | 2569 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5078 | 0.050 |
Why?
|
Workplace | 1 | 2007 | 863 | 0.050 |
Why?
|
HIV Infections | 1 | 2007 | 17346 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12710 | 0.050 |
Why?
|
Aged | 3 | 2022 | 169179 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 29588 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2023 | 617 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20555 | 0.040 |
Why?
|
Prevalence | 2 | 2021 | 15719 | 0.040 |
Why?
|
Biopsy | 1 | 2009 | 6768 | 0.030 |
Why?
|
Bangladesh | 1 | 2018 | 731 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1156 | 0.030 |
Why?
|
Antigens, Fungal | 1 | 2016 | 69 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 2019 | 495 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2019 | 275 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1001 | 0.030 |
Why?
|
Equipment Design | 1 | 2022 | 3510 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 908 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 41440 | 0.030 |
Why?
|
Risk Factors | 2 | 2021 | 74152 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1117 | 0.020 |
Why?
|
Drug Resistance | 1 | 2017 | 1597 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3889 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2548 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 59196 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5077 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 2016 | 1375 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2426 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7824 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3248 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10498 | 0.020 |
Why?
|
Parents | 1 | 2019 | 3564 | 0.020 |
Why?
|
Risk Assessment | 1 | 2021 | 23981 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26211 | 0.010 |
Why?
|
Infant | 1 | 2017 | 36202 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42251 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 26108 | 0.010 |
Why?
|